$0.9380
0.055.39%
At close: -
$0.9620
0.022.56%
After Hours: Dec 20, 9:13 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Indaptus Therapeutics in recent months.
Browse guidance and forecast on all stocks.